K192595 is an FDA 510(k) clearance for the ExSpiron 2Xi. Classified as Spirometer, Monitoring (w/wo Alarm) (product code BZK), Class II - Special Controls.
Submitted by Respiratory Motion (Watertown, US). The FDA issued a Cleared decision on December 17, 2019 after a review of 88 days - a notably fast clearance cycle.
This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1850 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.